World Journal of Otorhinolaryngology-Head and Neck Surgery (Dec 2020)

Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis

  • Daniel B. Spielman,
  • Jonathan Overdevest,
  • David A. Gudis

Journal volume & issue
Vol. 6, no. 4
pp. 207 – 213

Abstract

Read online

Patients with aspirin exacerbated respiratory disease (AERD) experience a severe and recalcitrant form of chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma, which are exacerbated by aspirin/NSAID ingestion. As compared with aspirin-tolerant CRSwNP, patients with AERD experience more severe olfactory dysfunction, which is one of the key contributors to the observed decrease in quality of life (QOL) in this disease. The objective of this paper is to review the published olfactory outcomes observed with various treatment modalities.

Keywords